|
|
|
Insider
Information: |
Malik Fady Ibraham |
Relationship: |
EVP Research & Develop... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
120,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,367,647 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
120,920 |
|
|
Total
Value |
$6,367,647 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
8
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-426.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-09-17 |
120,920 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-08-10 |
4 |
S |
$31.70 |
$79,250 |
D/D |
(2,500) |
158,164 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-09-14 |
4 |
S |
$34.86 |
$87,150 |
D/D |
(2,500) |
155,664 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-10-12 |
4 |
S |
$35.89 |
$89,725 |
D/D |
(2,500) |
153,164 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2023-11-09 |
4 |
S |
$35.40 |
$88,500 |
D/D |
(2,500) |
150,664 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-01-04 |
4 |
OE |
$7.96 |
$92,957 |
D/D |
11,678 |
162,651 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-01-04 |
4 |
AS |
$86.98 |
$1,363,712 |
D/D |
(15,678) |
146,973 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-02-06 |
4 |
AS |
$79.28 |
$2,585,497 |
D/D |
(32,605) |
142,973 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-02-06 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
175,578 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-04 |
4 |
D |
$67.68 |
$651,758 |
D/D |
(9,630) |
133,343 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-05 |
4 |
AS |
$67.53 |
$2,202,606 |
D/D |
(32,604) |
138,973 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-05 |
4 |
OE |
$6.67 |
$190,789 |
D/D |
28,604 |
167,577 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-06 |
4 |
D |
$66.88 |
$542,330 |
D/D |
(8,109) |
121,234 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,333 |
142,567 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-04-09 |
4 |
S |
$74.31 |
$2,422,918 |
D/D |
(32,605) |
138,567 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-04-09 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
171,172 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,417 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-05-07 |
4 |
AS |
$65.11 |
$1,012,265 |
D/D |
(15,547) |
137,056 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-05-07 |
4 |
OE |
$6.67 |
$94,621 |
D/D |
14,186 |
152,603 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-06-11 |
4 |
S |
$53.03 |
$413,106 |
D/D |
(7,788) |
135,004 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-06-11 |
4 |
OE |
$7.96 |
$43,159 |
D/D |
5,422 |
142,792 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-07-09 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
138,304 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-07-09 |
4 |
S |
$55.89 |
$408,103 |
D/D |
(7,300) |
131,004 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-07-23 |
4 |
S |
$57.02 |
$416,246 |
D/D |
(7,300) |
129,004 |
0 |
% |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-07-23 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
134,304 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
EVP Research & Development |
|
2024-08-06 |
4 |
S |
$53.70 |
$392,090 |
D/D |
(7,300) |
123,704 |
0 |
% |
|
132 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|